AN2 Therapeutics, Inc.
Pharmaceuticals · MENLO PARK, CA
PharmaceuticalsSEC Form D
AN2 Therapeutics, Inc. filed a Form D with the U.S. Securities and Exchange Commission on March 25, 2026, reporting $39,999,989 raised.
Incorporated in Delaware and based in MENLO PARK, CA, it operates in the Pharmaceuticals sector.
Companies file a Form D within 15 days of the first sale of securities in a private offering under Regulation D — an early, public signal that AN2 Therapeutics, Inc. has raised capital from private investors.
Browse more recently funded companies in Pharmaceuticals.
Executives & Directors
- Eric EasomExecutive Officer · Director
- Joshua EizenExecutive Officer
- Lucy DayExecutive Officer
- Sanjay ChandaExecutive Officer
- Joseph S. ZakrzewskiDirector
- Kabeer AzizDirector
- Rob ReadnourDirector
- Gilbert Lynn MarksDirector
- Stephanie WongDirector
- Patricia MartinDirector
- Melvin SpigelmanDirector
- Margaret FitzPatrickDirector
Recently funded in Pharmaceuticals
Other companies that recently filed a Form D
$3.0MRaised
FibroBiologics, Inc.
$200.0KRaised
Balsam Pharmaceuticals Co
$750.0KRaised
Eos SENOLYTIX, Inc.
$1.9MRaised
Liminatus Pharma, Inc.
$384.8KRaised